Estimated delivery in United States, on Monday 25 Nov 2024
Product Information
Name:
Navivumab
Description:
Navivumab (CT-P23) is a monoclonal antibody targeting influenza A's HA stem, neutralizing H1, H2, H5, and H9 viruses.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T77094 Navivumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
